MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract (NCT05432245) | Clinical Trial Compass
By InvitationNot Applicable
MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract
Panama, Spain, United Kingdom30 participantsStarted 2023-01-18
Plain-language summary
The study will assess safety and performance of MINIject implant in patients with open-angle glaucoma uncontrolled by topical hypotensive medications in conjunction with cataract surgery.
Who can participate
Age range40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of primary open angle glaucoma (POAG) in the study eye
* Operable age-related cataract eligible for phacoemulsification surgery with Intraocular Lens (IOL) implantation
* Glaucoma not adequately controlled with at least one topical hypotensive medication(s), unless the patient has an allergy / intolerance to a medication
* Patient must provide written informed consent to participate
Exclusion Criteria:
* Known or suspected allergy or hypersensitivity to medical silicone
* Allergy to fluorescein
* Presence of silicone oil in the study eye
* Individuals under tutorship or trusteeship
* Patient has a condition such that his / her ability to provide personal informed consent is compromised
What they're measuring
1
Proportion of study eyes achieving ≥ 20% reduction in diurnal IOP